Home Newsfeeds JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

JP Morgan analyst Brian Cheng initiates coverage on Senti Biosciences (NASDAQ:SNTI) with a Neutral rating.

Why Femasys Inc Stock Is Roaring Higher

By Erica Kollmann

September 29, 11:21 AM

Femasys Inc. (NASDAQ: FEMY) shares are trading higher Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13.

FEMY

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Avi Kapoor

December 7, 2:13 PM

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

AAMC

Marriott International Q2 Adj. EPS $1.80 Beats $1.54 Estimate, Sales $5.34B Beat $4.92B Estimate

By Bill Haddad

August 2, 7:03 AM

Marriott International (NASDAQ:MAR) reported quarterly earnings of $1.80 per share which beat the analyst consensus estimate of $1.54 by 16.88 percent. This is a 127.85 percent increase over earnings of $0.79 per share

MAR

Terra Classic Soars 25% While Bitcoin, Ethereum Take A Backseat Amid Do Kwon’s Growing Legal Woes

By Mehab Qureshi

November 27, 2:34 AM

Amidst the legal turmoil surrounding Terraform Labs and its founders, the cryptocurrency they created, Terra Classic (CRYPTO: LUNC) is blazing past Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: <

$LUNC

JP Morgan Initiates Coverage On Senti Biosciences with Neutral Rating

Related Posts

Why Femasys Inc Stock Is Roaring Higher

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

Marriott International Q2 Adj. EPS $1.80 Beats $1.54 Estimate, Sales $5.34B Beat $4.92B Estimate

Terra Classic Soars 25% While Bitcoin, Ethereum Take A Backseat Amid Do Kwon’s Growing Legal Woes